The Indian pharma industry is expected to grow at 15% to 20% to touch US$50 billion in value and India is on the path to become one of the largest pharmaceutical market by 2020.

The pharmaceutical firms, including global players in generics and vaccines, in the country are significant producer of APIs and formulations. By taking advantage of the low research and labour cost in India domestic pharmaceutical companies have become a major supplier to other emerging markets.

The Indian healthcare market is growing at a CAGR of ~16 per cent and is expected to reach USD 280 Bn by 2020. The rise of the incomes and lifestyle changes warrant a massive increase in healthcare facilities in India.